CYCLOMED is a deep tech startup focused in improve medical imaging by using new radioactive isotopes by using our technology, which is a compact cyclotron to produce Carbon-11 and Fluorine-18 labeled radiopharmaceuticals.
Our business model is based in licensing the IP and know-how with an exploitation model of our complete technology or its components.
CYCLOMED aspires to be a model not only in accelerator technology for medical applications, but also as an expert entity involved in the co-development and exploitation of enabling technologies (KET’s) to achieve the global challenges defined in Horizon Europe and meeting the sustainable development objectives, set by United Nations.
What we offer / Benefits:
- Medical cyclotron with reduced weight and size
- Lower energy consumption and less need for radiation protection
- Reduction in operative costs
- Single dose production
- Possibility of exploiting very short life radiopharmaceuticals